Price
$19.58+53.93%Social Signal Score
Analyst Ratings
10 analystsRevenue
$356.90M+221.53%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Jeffrey Lee Radke
- Sector
- Financial Services
- Industry
- Insurance - Property & Casualty
- Employees
- 862
- Beta
- -0.40
- Country
- KY
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 0.29
Financials
ARX has only 11 quarterly periods on file — the charts below show the full history available.
Revenue
$356.90M+221.5%Net Income
$78.70MEBITDA
$70.10M+525.9%Free Cash Flow
$-61.90M-162.7%EPS (diluted)
$0.35Shares Outstanding (diluted)
221.10M+15.7%Operating Expenses
$164.30MCash & Debt
$1.74BReturn of Capital
$70.40MRevenue by Segment (annual)
$430.90MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $879.50M | $-1.35B | $-7.49 |
| 2024 | $597.70M | $27.20M | $0.17 |
| 2023 | $329.70M | $-48.80M | $-0.30 |
| 2022 | $213.10M | $-91.70M | $-0.55 |
| 2021 | $103.20M | $-21.50M | $-0.13 |
Valuation
ARXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (8)
- Newsmarketbeat.com·32d ago·Neutral
Accelerant's Take-Private Deal Raises a Bigger Question for Insurance Stocks Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms announcing breakthrough results, for instance, not for an unglamorous firm connecting specialty insurance risk across a network of capital providers.
View source ↗ - Newszacks.com·49d ago·Positive
Why Is Accelerant Going Private Just One Year After Its IPO? ARX is going private just over a year after its IPO, as Thoma Bravo's $4 billion deal capitalizes on stronger operating results.
View source ↗ - Newszacks.com·53d ago·Positive
Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth ARX's Q2 earnings beat estimates as premium growth, higher fee revenues and stronger Exchange Services drive results.
View source ↗ - Newszacks.com·53d ago·Neutral
Accelerant Holdings (ARX) Reports Q2 Earnings: What Key Metrics Have to Say The headline numbers for Accelerant Holdings (ARX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
View source ↗ - Newszacks.com·54d ago·Positive
Accelerant Holdings (ARX) Tops Q2 Earnings and Revenue Estimates Accelerant Holdings (ARX) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.14 per share a year ago.
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
…ie & Holleman LLP, a law firm representing investors in securities and corporate governance matters, is investigating the proposed sale of Accelerant Holdings (NYSE: ARX) to private equity firm Thoma Bravo for $20.25 per share. The investigation focuses on the fairness of the transaction to Accelerant's public shareholders and potential conflicts arising from the participation of Altamont Capital Partners (“ACP”), Accelerant's controlling shareholder.
View source ↗ - Newswsj.com·54d ago·Neutral
Accelerant to Go Private in $4.4B Deal with Thoma Bravo The data-driven risk exchange agreed to go private in a deal with private-equity firm Thoma Bravo worth more than $4 billion.
View source ↗ - Newszacks.com·55d ago·Neutral
Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results? ARX's Q2 results may face pressure from weaker Underwriting and MGA profitability despite strong premium and investment income growth.
View source ↗
Earnings
Wed, Nov 11(in 5 weeks)
Consensus estimate $0.20 per share
Typical surprise +25.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$0.32 vs $0.16beat
- Wed, May 13$0.17 vs $0.16beat
- Wed, Mar 18$0.23 vs $0.16beat
- Wed, Nov 12$0.38 vs $0.22beat
- Thu, Aug 28$0.14 vs $0.13beat
- Mon, Jun 30$0.11 vs $0.12miss
Estimates and results for ARX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ARX officers and directors.
- Bought
- $1.9m
- Sold
- $28.4m
7 trades
26 trades
- Meriwether Karen Suesold
- Hasley Nancysold
- Oneill Francis Jamessold
- Oneill Francis Jamessold
- Radke Jeffrey Lsold
- Radke Jeffrey Lsold
- Oneill Francis Jamessold
- Oneill Francis Jamessold
67 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ARX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.